Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients

Leigh I G Iverson, Francis G. Duhaylongsod, J Nilas Young, Roger R. Ecker, Coyness L. Ennix, Richard L. Moretti, M. Farrar, R. Hayes, J. Lee, Ivan A. May

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

One hundred thirteen patients undergoing cardiopulmonary bypass were randomly assigned to receive either bovine or porcine heparin. Heparin was infused at 4.5 mg/kg during bypass and administered at the lesser of 70 units/kg or 5000 units/dose at 12-hour intervals postoperatively. Platelet counts decreased to 45% of preoperative levels during the first 3 days postoperatively (porcine, 44±13%, n =50; bovine, 46±15%), but returned to preoperative levels by the seventh postoperative day. The average blood loss in the porcine heparin group significantly exceeded that of the bovine heparin group (porcine, 1350.7±727.8 ml; bovine, 1059.6±381.0 ml; p<.01). Consequently, the platelet transfusion requirement was greater in the porcine heparin group (porcine, 1.7±3.9 units; bovine, 0.5±1.7 units; p<.05); however, blood and blood component (with the exception of platelets) administration was not significantly different between the two groups. The four patients taking anticoagulants or antiinflammatory agents in the porcine group required a mean of 8.5 units of red blood cells (RBC) plus supplemental platelets. The seven such patients in the bovine group received a mean of 3.0 units of RBC and no platelets. Thus, the use of porcine heparin resulted in a generalized increase in postoperative bleeding with increased management problems in patients undergoing cardiopulmonary bypass.

Original languageEnglish (US)
Pages (from-to)269-272
Number of pages4
JournalCardiovascular Drugs and Therapy
Volume4
Issue number1
DOIs
StatePublished - Jan 1990
Externally publishedYes

Fingerprint

Cardiopulmonary Bypass
Heparin
Swine
Hemorrhage
Blood Platelets
Erythrocytes
Platelet Transfusion
Platelet Count
Anticoagulants
Anti-Inflammatory Agents

Keywords

  • cardiopulmonary bypass
  • heparin
  • platelet aggregation
  • postoperative bleeding
  • protamine
  • thrombocytopenia

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Iverson, L. I. G., Duhaylongsod, F. G., Young, J. N., Ecker, R. R., Ennix, C. L., Moretti, R. L., ... May, I. A. (1990). Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients. Cardiovascular Drugs and Therapy, 4(1), 269-272. https://doi.org/10.1007/BF01857644

Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients. / Iverson, Leigh I G; Duhaylongsod, Francis G.; Young, J Nilas; Ecker, Roger R.; Ennix, Coyness L.; Moretti, Richard L.; Farrar, M.; Hayes, R.; Lee, J.; May, Ivan A.

In: Cardiovascular Drugs and Therapy, Vol. 4, No. 1, 01.1990, p. 269-272.

Research output: Contribution to journalArticle

Iverson, LIG, Duhaylongsod, FG, Young, JN, Ecker, RR, Ennix, CL, Moretti, RL, Farrar, M, Hayes, R, Lee, J & May, IA 1990, 'Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients', Cardiovascular Drugs and Therapy, vol. 4, no. 1, pp. 269-272. https://doi.org/10.1007/BF01857644
Iverson, Leigh I G ; Duhaylongsod, Francis G. ; Young, J Nilas ; Ecker, Roger R. ; Ennix, Coyness L. ; Moretti, Richard L. ; Farrar, M. ; Hayes, R. ; Lee, J. ; May, Ivan A. / Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients. In: Cardiovascular Drugs and Therapy. 1990 ; Vol. 4, No. 1. pp. 269-272.
@article{bedc009273e74ed1ae0c87b06297054d,
title = "Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients",
abstract = "One hundred thirteen patients undergoing cardiopulmonary bypass were randomly assigned to receive either bovine or porcine heparin. Heparin was infused at 4.5 mg/kg during bypass and administered at the lesser of 70 units/kg or 5000 units/dose at 12-hour intervals postoperatively. Platelet counts decreased to 45{\%} of preoperative levels during the first 3 days postoperatively (porcine, 44±13{\%}, n =50; bovine, 46±15{\%}), but returned to preoperative levels by the seventh postoperative day. The average blood loss in the porcine heparin group significantly exceeded that of the bovine heparin group (porcine, 1350.7±727.8 ml; bovine, 1059.6±381.0 ml; p<.01). Consequently, the platelet transfusion requirement was greater in the porcine heparin group (porcine, 1.7±3.9 units; bovine, 0.5±1.7 units; p<.05); however, blood and blood component (with the exception of platelets) administration was not significantly different between the two groups. The four patients taking anticoagulants or antiinflammatory agents in the porcine group required a mean of 8.5 units of red blood cells (RBC) plus supplemental platelets. The seven such patients in the bovine group received a mean of 3.0 units of RBC and no platelets. Thus, the use of porcine heparin resulted in a generalized increase in postoperative bleeding with increased management problems in patients undergoing cardiopulmonary bypass.",
keywords = "cardiopulmonary bypass, heparin, platelet aggregation, postoperative bleeding, protamine, thrombocytopenia",
author = "Iverson, {Leigh I G} and Duhaylongsod, {Francis G.} and Young, {J Nilas} and Ecker, {Roger R.} and Ennix, {Coyness L.} and Moretti, {Richard L.} and M. Farrar and R. Hayes and J. Lee and May, {Ivan A.}",
year = "1990",
month = "1",
doi = "10.1007/BF01857644",
language = "English (US)",
volume = "4",
pages = "269--272",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients

AU - Iverson, Leigh I G

AU - Duhaylongsod, Francis G.

AU - Young, J Nilas

AU - Ecker, Roger R.

AU - Ennix, Coyness L.

AU - Moretti, Richard L.

AU - Farrar, M.

AU - Hayes, R.

AU - Lee, J.

AU - May, Ivan A.

PY - 1990/1

Y1 - 1990/1

N2 - One hundred thirteen patients undergoing cardiopulmonary bypass were randomly assigned to receive either bovine or porcine heparin. Heparin was infused at 4.5 mg/kg during bypass and administered at the lesser of 70 units/kg or 5000 units/dose at 12-hour intervals postoperatively. Platelet counts decreased to 45% of preoperative levels during the first 3 days postoperatively (porcine, 44±13%, n =50; bovine, 46±15%), but returned to preoperative levels by the seventh postoperative day. The average blood loss in the porcine heparin group significantly exceeded that of the bovine heparin group (porcine, 1350.7±727.8 ml; bovine, 1059.6±381.0 ml; p<.01). Consequently, the platelet transfusion requirement was greater in the porcine heparin group (porcine, 1.7±3.9 units; bovine, 0.5±1.7 units; p<.05); however, blood and blood component (with the exception of platelets) administration was not significantly different between the two groups. The four patients taking anticoagulants or antiinflammatory agents in the porcine group required a mean of 8.5 units of red blood cells (RBC) plus supplemental platelets. The seven such patients in the bovine group received a mean of 3.0 units of RBC and no platelets. Thus, the use of porcine heparin resulted in a generalized increase in postoperative bleeding with increased management problems in patients undergoing cardiopulmonary bypass.

AB - One hundred thirteen patients undergoing cardiopulmonary bypass were randomly assigned to receive either bovine or porcine heparin. Heparin was infused at 4.5 mg/kg during bypass and administered at the lesser of 70 units/kg or 5000 units/dose at 12-hour intervals postoperatively. Platelet counts decreased to 45% of preoperative levels during the first 3 days postoperatively (porcine, 44±13%, n =50; bovine, 46±15%), but returned to preoperative levels by the seventh postoperative day. The average blood loss in the porcine heparin group significantly exceeded that of the bovine heparin group (porcine, 1350.7±727.8 ml; bovine, 1059.6±381.0 ml; p<.01). Consequently, the platelet transfusion requirement was greater in the porcine heparin group (porcine, 1.7±3.9 units; bovine, 0.5±1.7 units; p<.05); however, blood and blood component (with the exception of platelets) administration was not significantly different between the two groups. The four patients taking anticoagulants or antiinflammatory agents in the porcine group required a mean of 8.5 units of red blood cells (RBC) plus supplemental platelets. The seven such patients in the bovine group received a mean of 3.0 units of RBC and no platelets. Thus, the use of porcine heparin resulted in a generalized increase in postoperative bleeding with increased management problems in patients undergoing cardiopulmonary bypass.

KW - cardiopulmonary bypass

KW - heparin

KW - platelet aggregation

KW - postoperative bleeding

KW - protamine

KW - thrombocytopenia

UR - http://www.scopus.com/inward/record.url?scp=0025343157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025343157&partnerID=8YFLogxK

U2 - 10.1007/BF01857644

DO - 10.1007/BF01857644

M3 - Article

C2 - 2285620

AN - SCOPUS:0025343157

VL - 4

SP - 269

EP - 272

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 1

ER -